HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Reaps More Spiked Supplements From International Mail Shipments

This article was originally published in The Rose Sheet

Executive Summary

FDA identifies 14 products in examinations of international mail shipments found to contain approved and banned drug ingredients indicated for weight loss, erectile dysfunction and depression.

You may also be interested in...



FDA Using Ion Mobility Spectrometers In 4 IMFs, Plans Use In 4 More

Across all 9 IMF facilities in FY 2019, FDA screened around 25,200 parcels containing more than 41,000 products, detained more than 38,000 including 1,801 identified as supplements and expects to destroy more than 17,000.

FDA Regulatory Oversight No Impediment To Drug-Spiked Supplements, Study Finds

Products marketed for sexual enhancement or weight loss remain the most common types that contain undeclared drug ingredients,but drugs are showing up less in a third type that had been frequently found with drugs, bodybuilding supplements, says study in Journal of the American Medical Association. Researchers analyzing FDA database of tainted products marketed as supplements, say the trend didn't slow as FDA increased its GMP inspections and issued numerous warning letters.

Ion Spectrometer Improves FDA's Import Screening: Health And Wellness Industry News

FDA implementing ion mobility spectrometer devices for faster import screening; Kratom products recalled in Utah in salmonella investigation; ABC names Low Dog first Kronenberg Award winner; and AHPA revises liability insurance primer.

Related Content

Topics

UsernamePublicRestriction

Register

RS108494

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel